"Rosette Formation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells.
Descriptor ID |
D012397
|
MeSH Number(s) |
E01.370.225.812.706 E05.200.812.706 E05.478.594.730
|
Concept/Terms |
Rosette Formation- Rosette Formation
- Formation, Rosette
- Formations, Rosette
- Rosette Formations
- Immunocytoadherence
- Immunocytoadherences
|
Below are MeSH descriptors whose meaning is more general than "Rosette Formation".
Below are MeSH descriptors whose meaning is more specific than "Rosette Formation".
This graph shows the total number of publications written about "Rosette Formation" by people in this website by year, and whether "Rosette Formation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rosette Formation" by people in Profiles.
-
Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle in Children: Case Report and Literature Review. World Neurosurg. 2017 Nov; 107:1045.e9-1045.e16.
-
Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11.
-
Identification and expansion of human lymphokine-activated killer cells: implications for the immunotherapy of cancer. J Surg Res. 1987 Jun; 42(6):613-21.
-
Transient response of pure red cell aplasia to anti-thymocyte globulin in a patient with T-cell chronic lymphocytic leukemia. Am J Hematol. 1987 Mar; 24(3):285-91.
-
Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol. 1987 Feb; 5(2):208-15.
-
Human lymphokine-activated killer cells: further isolation and characterization of the precursor and effector cell. Nat Immun Cell Growth Regul. 1987; 6(6):291-305.
-
Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann N Y Acad Sci. 1987; 496:711-21.
-
Peripheral T cell lymphoma: immunologic and cell-kinetic observations associated with morphological progression. Blood. 1985 Oct; 66(4):980-9.
-
Lymphocyte function in human bone marrow. I. Characterization of two T cell populations regulating immunoglobulin secretion. J Immunol. 1985 May; 134(5):3036-41.
-
Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation. J Clin Invest. 1985 Jan; 75(1):234-41.